Hoover Financial Advisors’s CRISPR Therapeutics CRSP Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
$49K Buy
300
+200
+200% +$32.7K 0.01% 276
2021
Q1
$10K Hold
100
﹤0.01% 424
2020
Q4
$21K Buy
+100
New +$21K 0.01% 328